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Statistical Guidelines for Handling Missing Data
in Traumatic Brain Injury Clinical Research
Jessica L. Nielson,1,2 Shelly R. Cooper,3 Seth A. Seabury,4 Davide Luciani,5 Anthony Fabio,6
Nancy R. Temkin,7 Adam R. Ferguson8,9; and the TRACK-TBI Investigators*

Abstract

Missing data is a persistent and unavoidable problem in even the most carefully designed traumatic brain injury (TBI)
clinical research. Missing data patterns may result from participant dropout, non-compliance, technical issues, or even
death. This review describes the types of missing data that are common in TBI research, and assesses the strengths and
weaknesses of the statistical approaches used to draw conclusions and make clinical decisions from these data. We review
recent innovations in missing values analysis (MVA), a relatively new branch of statistics, as applied to clinical TBI data.
Our discussion focuses on studies from the International Traumatic Brain Injury Research (InTBIR) initiative project:
Transforming Research and Clinical Knowledge in TBI (TRACK-TBI), Collaborative Research on Acute TBI in Intensive
Care Medicine in Europe (CREACTIVE), and Approaches and Decisions in Acute Pediatric TBI Trial (ADAPT). In
addition, using data from the TRACK-TBI pilot study (n = 586) and the completed clinical trial assessing valproate (VPA)
for the treatment of post-traumatic epilepsy (n = 379) we present real-world examples of typical missing data patterns and
the application of statistical techniques to mitigate the impact of missing data in order to draw sound conclusions from
ongoing clinical studies.
Keywords: assessment tools; missing data; statistical guidelines; TBI

Introduction

T

raumatic brain injury (TBI) research is entering a new
phase of data-intensive studies that expands the horizon for
knowledge-based discovery. This special issue of the Journal of
Neurotrauma focuses on data analysis and statistical concerns attendant to this era of big data, as part of the International Traumatic
Brain Injury Research (InTBIR) Initiative. In this article, we focus
on the issue of missing data and discuss its implications for clinical
inference and outcome prediction in TBI research. Missing data is a
major and largely unrecognized factor that likely helps explain
imprecision in TBI research, contributing noise to outcome prediction and limiting the likelihood of sensitive and accurate detection of therapeutic efficacy in clinical trials.1 We will discuss the
brief history of missing data as a topic of statistical science, and
provide a review of best practices for measuring the impact of

missing data and of mitigation approaches that help ensure the
robustness of statistical inferences made in the face of missing data.
Using concrete examples from real-world TBI data, this review
focuses on practical application of statistical methods, rather than
intensive mathematics, with the goal of offering TBI researchers
guidelines and best practices for dealing with missing values.
The field of missing data as a statistical problem is fairly young,
having only been developed since the early 1970s, when computer
programs began to help statisticians carry out complex calculations
unapproachable by hand. This gave rise to a set of methods known
collectively as missing values analysis (MVA). The seminal research for MVA was first described by Rubin in 1976,2 followed
by a comprehensive set of guidelines for application of methods
for MVA in 2002.3,4 Since its inception, MVA has been widely
adopted to make sense of population statistics when portions of the
data are missing.
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HANDLING MISSING DATA IN TBI RESEARCH
There are only a handful of published studies discussing MVA’s
application to missing data specifically for TBI. Childs and coworkers attempted to describe and categorize why data were missing in TBI patients who were monitored for both brain temperature
and intracranial pressure (ICP), and identified several etiologies,
including sensor failures resulting from disconnections.5 A second
article by Feng and coworkers assessed the feasibility of dealing
with missing brain temperature and ICP data, focusing on the potential value of re-using old monitoring data that had previously
excluded from analyses because they were not complete.6 A third
article by Zelnick and coworkers focused on imputing outcome
data as measured by the Glasgow Outcome Scale Extended (GOSE) in order to maximize the usefulness of the GOS-E as a primary
outcome even if participants dropped out.7 A very recent systematic
review by Richter and coworkers revealed that TBI clinical research rarely addresses the issue of missing data despite the fact that
missing data are common.8 Accordingly, the latest edition of the
highly cited clinical prediction modeling textbook by Steyerberg
devotes two chapters to dealing with missing data, including a
general overview with references to TBI, and a chapter devoted to
a case study of MVA in TBI from the International Mission for
Prognosis and Analysis of Clinical Trials in TBI (IMPACT-TBI)
study.9,10 The present article complements this prior work and reviews additional approaches for dealing with missing data. In addition, we illustrate the impact of missing data using participantlevel analysis of two recent TBI studies, a clinical trial of valproate
(VPA) and the Transforming Research And Clinical Knowledge for
TBI Pilot study (TRACK-TBI Pilot).
Here, we ask readers to imagine a scenario in which patients are
enrolled in a clinical study to develop prediction models for prognosis
and long-term outcome following TBI based on factors that are inherent both in an individual’s pre-existing medical history, and aspects of the neurocritical care received after admission to the
emergency room. Throughout the course of this study, some data are
missing for nearly every patient. Common problems include loss to
follow-up, comorbid conditions that prevent data collection for a
specific time point, and instrumentation problems, among others.
Some of these sources of missingness may be random, such as lack of
follow-up data resulting from unforeseen circumstances in patients’
lives. Examples of this from the TRACK-TBI Pilot study included
participants who were homeless and therefore either unwilling to
come in for follow-up testing, or could not be reached. Others may be
systematic, such as lack of follow-up care caused by infrastructure
problems at the hospital (e.g., insufficient staff coverage, equipment
failures, or magnetic resonance imaging (MRI) scanner out of service
). Failure to account for the explanation of the missing data could
introduce bias, limiting both the generalizability and reproducibility
of the findings, and in fact, may be problematic for deriving conclusions about the primary outcomes: prognoses and long-term outcome.
At the completion of the study, how should one handle the missing
data? How may we assess the significant missing patterns in our study
while maximizing the contribution that may otherwise be lost when
patients are excluded simply because some of their data are missing?
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lated with other variables in the data set. MAR indicates that
missingness is correlated with some variables, but not key variables
of interest to analysis. NMAR indicates that missingness is associated with key variables (e.g., outcome). Many studies have simply described data MNAR as being ‘‘problematic,’’ with no clear
guidelines for how to fill in the missing data patterns, other than by
modeling.11 More frequently, MNAR is simply overlooked and
unreported.
The Little’s test is a descriptive analytic tool to assess whether
data are MCAR.12 A variable (e.g., cognitive outcome) with
MCAR has a pattern of missingness that is not associated with other
variables (e.g., age, gender, socioeconomic status, or poor function), but is rather a random occurrence of missingness that cannot
otherwise be explained. Commonly used statistical software packages, such as SPSS (IBM, Inc.), have MVA modules for determining whether the data are MCAR. To run a Little’s test in SPSS,
the variables of interest are selected within the missing values
analysis module, and analyzed using the expectation maximization
(EM) function. The resulting output will return a significance test
under the EM means generated. If p < 0.05, then the data fail the
Little’s test and the data are not MCAR. If this is the case, some
statisticians have recommended that nothing more be done to fill in
the missing data patterns, and that only complete-case analyses can
be used.13 This is potentially problematic, however, because it can
introduce bias in the data set by not accounting for the reason for the
missingness, and violating assumptions about the sample population being studied.14 Alternative models known as sensitivity analyses15 can be performed when data are not missing at random
(NMAR), which will be discussed subsequently.
If the data are MCAR or MAR, data modeling approaches help
test whether missing values impact statistical results (discussed in
detail subsequently). Simple methods include t tests or logistic
regression analyses on incidence of missingness to determine if
variables such as early poor performance, age, gender, or education
level can explain differences about whether data were collected or
not. More advanced methods involve using non-missing values to
predict individual missing values. Noise is added to the predicted
value to avoid awarding unwarranted precision to the values. This
is done multiple times, with the analyses repeated on each set; the
final analysis takes into account both the individual tests and how
much they differ from one another.12,16 This enables researchers to
indirectly measure the probability that missing values impact the
statistical results.
Methods for Handling Missing Data for Analysis
Once missingness has been diagnosed, a number of methods
exist to mitigate the impact of missing values (Table 1). Richter and
coworkers put together a practical decision tree helping researchers
handle missing data.8 Our Table 1 provides recommondations that
align with this decision tree; however, we extend this prior work
with examples of additional methods reviewed subsequently in
detail.
Complete-case analysis

Diagnosing Missingness and MVA
The initial steps in any approach are to analyze whether data are
missing at random (MAR) or completely at random (MCAR), or,
most commonly in TBI research, whether data are missing not at
random (MNAR). The first incidence of missing data is flagged
using the ‘‘missingness’’ label and coded as a binary variable
(yes = 1 vs. no = 0). MCAR indicates that missingness is uncorre-

The simplest way to analyze data that have missing values is to
drop any patients who do not have the complete set of variables
collected, and test the patterns of the raw data. This approach,
known as ‘‘listwise deletion,’’ is the default for most statistical
packages when researchers apply traditional analytics including
regression approaches, analysis of variance, t tests, and oddsratios tests among others. Although this type of analysis appears
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Table 1. Summary of Missing Values Analyses (MVA) Recommended
for Traumatic Brain Injury (TBI) Clinical Research
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Type of MVA
Complete-case analysis
Partial deletion
Mean or mode substitution
Expectation maximization (EM)
Multiple imputation (MI)
Sensitivity analysis (SA)
Inverse probability weighting (IPW)

Assumptions
None
MCAR or
MCAR or
MCAR or
MCAR or
NMAR
NMAR

MAR
MAR
MAR
MAR

Recommended for TBI
No
No
No
No
Yes, combined with appropriate modeling through SA
Yes
Yes, with appropriate modeling of confounders of missingness

MCAR, missing completely at random; MAR, missing at random; NMAR, not missing at random.

straightforward, it creates a biased sampling of the population
based on potential latent variables or patterns that could explain the
source/cause for the missing data, if the data are MAR or NMAR.
Because listwise deletion is the default for most statistical analyses,
it is likely that researchers are often unaware of biases introduced
by complete-case analyses. This method of data analysis is not
recommended for TBI clinical research, and can lead to biased and
unreliable findings.
Partial deletion
Partial deletion approaches may be useful to maximize the raw
data by only including variables that have the most complete data
across the study population. Most statistical software packages
have an option for most types of statistical tests to delete cases in
either a listwise or a pairwise fashion. Listwise deletion will automatically drop patients from the analysis if they are missing one
or more data points from the list of variables included in the model,
whereas pairwise deletion will still include patients who may have
some missing data points in the included variables. The analysis
will exclude those variables when the data are missing, while still
completing analysis of other variables and cases with complete
data. However, partial deletion approaches make the assumption
that the data are either MCAR or MAR and does not apply for data
that are NMAR.
Mean and mode substitution
Other methods involve replacing missing values based on observed values; for example, using mean or mode substitution. The
reliability of these methods to accurately model the missing data is
questionable, as they may skew the data if the values that are
missing do not truly fall within the same distribution of the group
mean or mode of the variable. This type of method does not rely
on the relationships in the covariance matrix of the existing data
patterns, but rather replaces any missing values within each variable with either the mean or mode value for that variable. This is
problematic for the following reasons.
Here, we ask readers to imagine that there are data missing
on the same 6-month outcome measure—the Wechsler Adult
Intelligence Scale (WAIS)—from two different patients for different reasons. One of the patients may not have data because that
individual was so low functioning as to be unable to perform the
WAIS assessment, and, therefore, no data were collected. The
other patient may have been so high functioning that the individual had no interest in returning for follow-up assessment and
therefore also does not have WAIS data collected. If only the data
within WAIS are taken into account when filling in the missing
data, either based on the mean or the mode, both patients would

get the same score, despite that had their data been collected, they
would have scored very differently from each other.
Multiple imputation (MI)
When it is determined that the data are MCAR or MAR, EM can
be used for a partial imputation of the data. The benefit of a more
rigorous approach, known as MI, is that missing values are replaced
with data based on the known relationships that exist in the completed data. These relationships are then used to make assumptions
about how specific patients would score on the missing measures,
compared with how the patient population performed collectively.
As noted, EM is a method that iterates through the data to find the
maximum likelihood estimation that can estimate the parameters
of a statistical model, given specific observations in the data. This
method assumes that unobserved latent variables are in the model,
and the combination of expectation and maximization of the loglikelihood is used to derive the latent variable distribution (e.g., the
missing data). However, if a complete imputation is desired, MI can
be performed to fill in missing information in order to boost the
analytical sample size. Investigators may then potentially infer
what value the missing data may have.
Previous recommendations for multiple imputation originally
described by Rubin4 suggested that approximately three to five
imputations are sufficient in order to fill in missing data. Although
imputing data with only three to five iterations may not change the
sample mean or standard error and the general inferences that can
be drawn from the imputed results, others have suggested that if
effect sizes in the data set are low, having fewer total imputations
runs the risk of decreasing the statistical power of the analyses, and
therefore reducing the ability to detect statistical significance between groups.17 Additionally, the proportion of missing data is
a factor in deciding how many imputations to use to maximize
efficiency and yield accurate inferences for power and effect
sizes. Monte Carlo simulations were performed by Graham and
colleagues17 to estimate the appropriate number of imputations
needed, based on the proportion of missing data, to yield results
approaching the power that the study would have were there no
missing data (Fig. 1). Theoretically, it is possible to include data
that are missing at high percentages of the total data, but in order to
maximize power, the number of necessary imputations increases
according to the amount of data missing. Multi-level modeling
approaches such as modern linear mixed-effect models provide
mechanisms to extend imputation to multi-level nested designs, in
which missingness may occur in the pattern of higher-order interactions. A full review of these methods is beyond the scope of the
present review, but we refer interested readers to prior work by
Goldstein and colleagues.18 Similarly, advanced methods exist to
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FIG. 1. Monte Carlo simulations for number of imputations needed to maximize effect sizes based on percentages of missing data
(adapted from Graham and coworkers17). Color image is available online.
assess latent trajectory classes in time series data that apply mixture
modeling to missingness in time series data, and these approaches
have recently been applied to TBI outcomes.19 Extended discussion
of these approaches is beyond the scope of the current review, but
we refer interested readers to prior work.20
Sensitivity analyses
Sensitivity analysis is an in silico method used in clinical trials to
assess whether certain aspects of the study results can be altered
simply by arbitrarily changing a single parameter of the experimental design.15 For example, here we ask readers to consider a
hypothetical TBI study that finds that hyperthermia produces worse
outcome, while controlling for common covariates such as sex.
Sensitivity analysis may involve statistically correcting for sex,
and assessing whether this dramatically alters the pattern of significance. If sensitivity analysis reveals that the sex covariate dramatically changes the observed relationship, this would suggest
that the results are highly sensitive to the sex variable and may not
generalize to another population with a different distribution of
males versus females.
A similar method is useful when there may be biases as to why
data are missing. Here, sensitivity analysis involves using a mixture
modeling approach to compare data distributions when data are
missing and non-missing. First, variables are imputed using the
MAR assumption by applying machine learning tools such as EM
or regression modeling to estimate and fill in missing data points.3
Then, the data distributions and descriptive statistics for significant
differences between the raw, unimputed data set and the imputed
data set2–4 are tested. Significant differences between imputed and
non-imputed data sets indicate that missing data cannot be ignored,
establishing that they are NMAR. This analysis can be expanded by
introducing variables affected by imputation as covariates to test
their impact as candidate NMAR mechanisms and establish the
threshold at which data cannot be imputed. In TBI, for example, if
blood pressure has a significant impact on functional recovery, but
blood pressure data are known to be NMAR, a model can be developed to determine the threshold at which blood pressure data can
be imputed that both doesn’t significantly change the data distributions and maintains precision in outcome prediction. The Multivariate Imputation by Chained Equations (MICE) package in R
can be used for these purposes, where mulitiple imputation can be
nested within a sensitivity analysis to test for these sensitivity

thresholds when performing MI.21,22 Unfortunately, the results of
these types of analyses are not prominently reported in medical
journals in general, and even less so in randomized controlled
clinical trials.15 However, multiple experts in the field of MVA
agree that when data are NMAR, which is the case in most clinical
trials and research, performing sensitivity analysis is crucial to
reduce unintended bias.23 This procedure can be implemented in
combination with MI, provided that the influence of the missing
data and its source can be accurately modeled.24,25
Inverse probability weighting
Inverse probability weighting allows inverse weighting to be
applied to certain patients in the data set who are skewing results
because of missingness and/or dropout. If the source of the missing
or confounding data is known, it can be used to weight the data
similarly to regression analyses to remove the influence on the
study results.26,27 This is also similar to sensitivity analysis. These
approaches look at confounding when comparing groups that differ
in incidence of missingness, and the missingness is related to both
group assignment and outcome (i.e., NMAR).
Practical Application of MVA to Real-World TBI
Participant-Level Clinical Research Data
Although the modeling approaches we recommend (sensitivity
analysis, inverse probability weighting, and, to a lesser extent,
multiple imputation) may be applied post hoc, the optimal method,
described subsequently, is to provide detailed codes regarding why
data is missing at each stage of the study so that they can be included in statistical models that aim to account for the impact that
the missing confounders have on outcome.
In this section, we present data from real-world examples of
missing values analysis applied in the context of past and ongoing
TBI clinical studies. We first explore missing data patterns in the
TRACK-TBI Pilot study,28 in which the cause of missing data
patterns was not known. The second example tests hypotheses
about the potential causes of missing data in the completed clinical
trial assessing VPA for the treatment of post-traumatic epilepsy,29
in which similar outcomes were collected and specific coding was
included in the study design to account for why data were not
collected for each patient at each phase of the study.
Figure 2 shows how patients recover on measures of verbal
learning either measured by the California Verbal Learning Task
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FIG. 2. Recovery curves for cognitive function as measured by verbal learning tasks grouped by first reported measure of Glasgow
Outcome Scale (GOS). (A–C) Top row are data from Study 1 (Transforming Research and Clinical Knowledge in Traumatic Brain
Injury [TRACK-TBI] pilot) assessing neuropsychological testing measured by the California Verbal Learning Task (CVLT) normative data, blocked by their first GOS-Extended (GOS-E) rating at 3 months post-TBI, looking at either complete case analysis (A), or
with missing data filled in by either expectation maximization (EM) (B), or multiple imputation (MI) (C). The bottom row are data
from Study 2 (valproate [VPA]) using similar outcomes, in which the verbal learning was assessed using a Selective Reminding task
and an older version of the GOS in which functional deficits were previously grouped into single categories for mild (green),
moderate (blue), and severe (red) disability, with similar comparisons across complete case analysis (D), or EM-filled (E) or MI-filled
(F) data sets. Color image is available online.

FIG. 3. Missing data patterns for verbal learning tasks blocked by Glasgow Outcome Scale (Extended) (GOS[E]) score at each of the
three time points for each study. (A–C) Percent of missing data for the California Verbal Learning Task (CVLT) in study 1 (Transforming
Research and Clinical Knowledge in Traumatic Brain Injury [TRACK-TBI) Pilot) between 6 and 12 months based on GOS-E scores at
either 3 months (A), 6 months (B), or 12 months (C) post-TBI. (D–F) Percent of missing data for Selective Reminding in study 2
(valproate [VPA]) among 1, 6, and 12-months post-TBI based on GOS scores at those same time points. Patients with less disability (green
lines) show a marked increase in missing data at the final time point when blocked by their GOS(E) at 1, 3, or 6 months, with a flat line at
the 12-month mark indicating that the higher functioning patients did not have data for the final time point. Also of note are the black and
gray lines that represent patients who either died (GOS[E] 1) or were in a vegetative state (GOS[E] 2) before the first time point and
therefore show no change in missing data over time, with the exception of more data being collected over time for patients starting out at a
GOS score of 2 at 1 month, and presumably improving and therefore being able to have Selective Reminding assessed. +GOS scores 3, 4,
and 5 are an older version of the GOS-E, where 3/4, 5/6, and 7/8 have since been extended, respectively. Color image is available online.
2534
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FIG. 4. Study 2 (valproate [VPA]) had codes for the reason for the missing data measured at 1 month (A), 6 months (B), and 12 months
(C) to confirm hypotheses about why outcome data were missing for different groups of patients in the Transforming Research and
Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot, blocked by Glasgow Outcome Scale (GOS) severity. As expected,
patients from the VPA study who were higher functioning (green) were less likely to participate in follow-up care, potentially a as a result
of a lack of interest in staying in the study because they did not have a measurable disability. Whereas patients with severe disability (red)
were more likely to have missing data because of central nervous system (CNS) problems preventing them from performing the task.
Patients who started in a vegetative state (white) at 1 month generally could not be assessed because of CNS complications, with,
presumably, patients moving to either the red category (out of a vegetative state, severe disability), or into the black category (dead).
Color image is available online.
(CVLT) in the TRACK-TBI Pilot study, or the Selective Reminding Task in the VPA study, blocked by their initial score on the
GOS or GOS-E in the TRACK-TBI Pilot. Patients are also grouped
based on changes in GOS(E) over the course of each study. There is
a similar pattern of recovery between the two studies, providing a
rationale for potential conclusions to be drawn about patient recovery, and potential sources of missingness. For this analysis of
neurocognitive outcomes, we limited the analysis to GOS(E) scores
beyond persistent vegetative state (GOS[E] >2). Comparisons
are shown in Figure 2 for how these recovery curves differ between either complete case analysis (Fig. 2A,D), EM-filled data
(Fig. 2B,E), or MI-filled data (Fig. 2C,F). The results demonstrate
important features of missing values analysis: (1) the method used
to impute data can have a large potential impact on the estimated
variance as well as the estimated means (Fig.2B vs. Fig.2C), and (2)
multiple imputation can recapitulate fundamental patterns in raw
data while reducing error variance, which has the potential to boost
statistical power (Fig.2A vs. 2C). However, the findings also raise
cautionary points. By compairing the percent missing (Fig. 3) with
the filled case analysis (Fig.2C, F) it is clear that EM and MI
approaches assigned values for some patients who were untestable
for central nervous system (CNS) reasons (or death). In this sense,
the MI glossed over the poor functioning of this subset of subjects.
Indeed, the primary authors of Study 2 report that if the examiners
gave the word list and waited a minute for the person to respond,
most of the GOS 3s who were untestable for CNS reasons would
have recalled none of the words and recieved a score of 0. It is worth
mentioning that the original analysis of this study assigned 1 (CNS)
or 2 (Death) points less than the worst observed score, to acknowledge the poor functional level of these patients, and ranked
analysis was used. This reflects a powerful alternative approach for
handling missing data, which reflects deep domain knowledge and a
priori planning for handling missing data at the study design stage.
Figure 3 shows the proportion of missing data at each time point
for each study on the verbal learning task data blocked again by
disability severity measured on the GOS(E). Again, we see similar
patterns between the two studies, suggesting that we may be able

to make predictions about the cause of missing data in the
TRACK-TBI Pilot that were not specifically coded, as was done in
the VPA study. This is explored in Figure 4, where specific codes
were documented regarding the reason for missing data on the
Selective Reminding task at each phase of the study. Reasons
included death, inability to perform the task because of either
physical or CNS complications, being unreachable or unwilling to
return for follow-up, and English being a second language (ESL),
thus preventing subjects from accurately performing the task in
English. The studies’ similar patterns for recovery curves and
rates of missing data from global disability and verbal learning
measures may permit us to retrospectively perform sensitivity
analyses on the TRACK-TBI Pilot data to more accurately model
the confounding factors contributing to missing data patterns and,
in turn, help fill in missing data. Examples include assumptions
about patients with a higher score on the GOS-E (7 or 8) presumably performing very well on the CVLT at 6 and 12 months
when data are otherwise missing because patients are unwilling to
return for follow-up. Conversely, lower scores on the GOS-E (3 or
4) may include assumptions about poor performance resulting
from underlying brain pathology causing CNS complications so
severe that the patients are unable to perform the task, providing
more information about the pathophysiology of their injuries.
Conclusion
In conclusion, careful attention to TBI trial design to prevent, as
far as possible, missing data from occurring, is ideal, but planning
ahead with detailed coding protocols to account for the reasons for
missingness acknowledges and mitigates the reality of human research. When possible, sensitivity analysis should be conducted to
account for confounding factors that are contributing to the missing
data and thus impacting outcome. Being able to specifically label
why data are missing allows that information to be included in the
statistical models where confounding variables can be corrected
for, and additional meaningful sources of missingness can be considered as their own outcomes. This is particularly so when they
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affect patients’ ability to be helped or harmed by their treatment
and participation in the research.23 As with TBI clinical care,
prevention is the key to future success.
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